首页> 外文OA文献 >PMH19 COMPARATIVE ANALYSIS OF THE EFFICACY AND SAFETY OF ESCITALOPRAM WITH SERTRALINE AND VENLAFAXINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

【2h】

PMH19 COMPARATIVE ANALYSIS OF THE EFFICACY AND SAFETY OF ESCITALOPRAM WITH SERTRALINE AND VENLAFAXINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

机译：PMH19联合舍曲林和文拉法辛治疗严重抑郁症（MDD）的疗效和安全性比较分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Walczak J; Matysiak S; Rowinska M;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. [J] . Matrisciano F, Bonaccorso S, Ricciardi A, Journal of psychiatric research . 2009,第3期

机译：舍曲林，依他普仑或文拉法辛治疗6个月后，患有严重抑郁症（MDD）的患者BDNF血清水平的变化。
2. Comparison of the efficacy and safety of sertraline, reboxetine, and venlafaxine in patients with major depressive disorder: a pooled analysis of four randomized, open-label trials [J] . C Akkaya, S Kirli, SS Eker, Bulletin of Clinical Psychopharmacology . 2010,第4期

机译：舍曲林，瑞波西汀和文拉法辛在重度抑郁症患者中的疗效和安全性比较：四个随机，开放标签试验的汇总分析
3. Comparison of The Efficacy and Safety of Sertraline, Reboxetine, and Venlafaxine in Patients with Major Depressive Disorder: A Pooled Analysis of Four Randomized, Open-Label Trials [J] . Cengiz Akkaya, Selcuk K?rl?, Salih Saygin Eker, Psychiatry and Clinical Psychopharmacology . 2010,第4期

机译：舍曲林，瑞波西汀和文拉法辛在重度抑郁症患者中的疗效和安全性比较：四个随机，开放标签试验的汇总分析
4. A Comparative Audio Stimulus - fMRI study of Major Depressive Disorder(MDD) and Never Depressed (ND) Subjects [C] . Seema P D, Preetham Shankapal IEEE International Conference on Electronics, Computing and Communication Technologies . 2018

机译：严重抑郁症（MDD）和从未抑郁（ND）受试者的比较音频刺激-fMRI研究
5. The impact of efficacious treatments for major depressive disorder on remission rates of specific symptoms: A re-analysis of the Treatment of Depression Collaborative Research Program. [D] . Stewart, Jeremy Gordon. 2009

机译：有效治疗重度抑郁症对特定症状缓解率的影响：《抑郁症治疗合作研究计划》的重新分析。
6. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline escitalopram or venlafaxine [O] . Francesco Matrisciano, Stefania Bonaccorso, Angelo Ricciardi, -1

机译：舍曲林依他普仑或文拉法辛治疗6个月后患有严重抑郁症（MDD）的患者BDNF血清水平的变化
7. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. [O] . MATRISCIANO F, BONACCORSO S, RICCIARDI A, 2009

机译：舍曲林，依他普仑或文拉法辛治疗6个月后，患有重度抑郁症（MDD）的患者BDNF血清水平的变化。

PMH19 COMPARATIVE ANALYSIS OF THE EFFICACY AND SAFETY OF ESCITALOPRAM WITH SERTRALINE AND VENLAFAXINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

著录项

引文网络

相似文献

相关主题

期刊订阅